Choosing which sessions to attend at ASCO can be overwhelming, given the number of high-value research reports being shared. In this article, we’ve curated the top 10 presentations you don’t want to miss at this year’s event.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
1:54-2:06 PM EDT, Monday, June 5
Abstract# 4505
5:24-5:36 PM EDT, Monday, June 5
Abstract# 10505
10:24-10:36 AM EDT, Monday, June 5
Abstract# 6005
5:12-5:24 PM EDT, Monday, June 5
Abstract# 9504
12:30-2:00 PM EDT, Monday, June 5
Abstract# 7010, Poster bd# 140
Monday, June 5
12:30-2:00 PM EDT
Abstract# 7016, Poster bd# 146
5:30-7:00PM EDT, Monday, June 5
Abstract# 6017, Poster bd# 9
5:30-7:00 PM EDT, Saturday, June 3
Abstract# 3510
2:15-5:15 PM EDT, Saturday, June 3
Abstract# 2060, Poster bd# 417
2:15-5:15 PM EDT, Saturday, June 3
Abstract# 6603, Poster bd# 95
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access
Key learnings from DESTINY trials
Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors
Study of 401,576 patients reveals differences in cancer burdens as well as overall survival
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy